KING MICHAEL (CHIEF FINANCIAL OFFICER) purchased 5K shares of SAB BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $4.5K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/30/2023ACC: 0000950170-23-067072
Officer· CHIEF FINANCIAL OFFICER
Since Oct 2023
+5K
Net shares
Net buyer
$4.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$0.90
Trade value
$4.50K
% of position
New position
11/30/2023
0.00→5K
Total
Net shares
+5K
Net value
$4.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/30/2023 | P · Purchase | +5K | $0.90 | $4.50K | New position | 0.00 | 5K |
| Total | +5K | $4.50K | ||||||
Derivative Transactions0
No derivative transactions reported